Apixaban Versus Rivaroxaban in Non Valvular Atrial Fibrillation
Clinical trial NCT06862726 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06862726
- Sponsor
- Les Laboratoires des Médicaments Stériles
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-01
- Primary completion
- 2025-12-31
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.